Search Results

PEARL Registry Supports Boston Scientific's AngioJet Rheolytic Thrombectomy System for DVT

June 24, 2015—In the Journal of Vascular and Interventional Radiology (JVIR), Mark J. Garcia, MD, et al published the procedural and patient outcomes from the prospective, multicenter PEARL registry, which evaluated peripheral use of the AngioJet rheolytic thrombectomy (RT) system (Boston Scientific Corporation) with a variety of catheter lengths in the endovascular management of deep vein thrombosis (DVT) of the lower extremity (2015;26:777–785).

Dr. Mark Garcia Appointed as Chief Medical Officer of Vesper Medical

March 4, 2019—Vesper Medical, Inc., a developer of venous stent solutions for peripheral vascular disease, announced the appointment of interventional radiologist Mark J. Garcia, MD, as its Chief Medical Officer.

ACCESS PTS Study Supports Boston Scientific’s EkoSonic System to Treat Postthrombotic Syndrome

February 27, 2020—Results from the ACCESS PTS study of ultrasound-accelerated thrombolysis and venoplasty for the treatment of the postthrombotic syndrome (PTS) were recently published by Mark J. Garcia, MD, et al online in Journal of the American Heart Association (JAHA). The study evaluated acoustic pulse thrombolysis using the EkoSonic endovascular system (Boston Scientific Corporation) to treat PTS, which is a common complication of deep vein thrombosis (DVT) with limited treatment options.

Study at SIR Shows Endovascular Treatment of Chronic DVT May Ease Postthrombotic Syndrome

March 26, 2012—Data presented at the Society of Interventional Radiology's (SIR) annual scientific meeting in San Francisco demonstrated that endovascular treatment of chronic deep vein thrombosis (DVT) reduced disabling symptoms and improved the quality of life for patients experiencing postthrombotic syndrome. The study was led by Mark J. Garcia, MD, who also serves as Chair of SIR's Venous Service Line.

Embolization Inc.’s Polymer-Based NED Coil Used in First Procedure

November 10, 2025—Embolization, Inc. announced that its polymer-based coil intended for arterial and venous embolization in peripheral vasculature was used in its first procedure.

Embolization, Inc.’s Polymer-Based NED Coil Evaluated in Limited-Market Release 

April 7, 2026—Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which is a radiopaque, polymer-based embolic coil.